Literature DB >> 25880472

Method optimization for fecal sample collection and fecal DNA extraction.

Conny Mathay1, Gael Hamot, Estelle Henry, Laura Georges, Camille Bellora, Laura Lebrun, Brian de Witt, Wim Ammerlaan, Anna Buschart, Paul Wilmes, Fay Betsou.   

Abstract

BACKGROUND: This is the third in a series of publications presenting formal method validation for biospecimen processing in the context of accreditation in laboratories and biobanks. We report here optimization of a stool processing protocol validated for fitness-for-purpose in terms of downstream DNA-based analyses.
METHODS: Stool collection was initially optimized in terms of sample input quantity and supernatant volume using canine stool. Three DNA extraction methods (PerkinElmer MSM I®, Norgen Biotek All-In-One®, MoBio PowerMag®) and six collection container types were evaluated with human stool in terms of DNA quantity and quality, DNA yield, and its reproducibility by spectrophotometry, spectrofluorometry, and quantitative PCR, DNA purity, SPUD assay, and 16S rRNA gene sequence-based taxonomic signatures.
RESULTS: The optimal MSM I protocol involves a 0.2 g stool sample and 1000 μL supernatant. The MSM I extraction was superior in terms of DNA quantity and quality when compared to the other two methods tested. Optimal results were obtained with plain Sarstedt tubes (without stabilizer, requiring immediate freezing and storage at -20°C or -80°C) and Genotek tubes (with stabilizer and RT storage) in terms of DNA yields (total, human, bacterial, and double-stranded) according to spectrophotometry and spectrofluorometry, with low yield variability and good DNA purity. No inhibitors were identified at 25 ng/μL. The protocol was reproducible in terms of DNA yield among different stool aliquots.
CONCLUSIONS: We validated a stool collection method suitable for downstream DNA metagenomic analysis. DNA extraction with the MSM I method using Genotek tubes was considered optimal, with simple logistics in terms of collection and shipment and offers the possibility of automation. Laboratories and biobanks should ensure protocol conditions are systematically recorded in the scope of accreditation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25880472     DOI: 10.1089/bio.2014.0031

Source DB:  PubMed          Journal:  Biopreserv Biobank        ISSN: 1947-5543            Impact factor:   2.300


  21 in total

1.  Comparison of Loop-Mediated Isothermal Amplification and Real-Time PCR Assays for Detection of Strongyloides Larvae in Different Specimen Matrices.

Authors:  Matthew R Watts; Rady Kim; Vishal Ahuja; Gemma J Robertson; Yasmin Sultana; Michael C Wehrhahn; Richard S Bradbury; Gwendolyn L Gilbert; Rogan Lee
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

2.  Biofluids manipulation methods for liquid biopsy in minimally-invasive assays.

Authors:  Valeria Garzarelli; Francesco Ferrara; Elisabetta Primiceri; Maria Serena Chiriacò
Journal:  MethodsX       Date:  2022-06-17

3.  Moxidectin Effects on Gut Microbiota of Wistar-Kyoto Rats: Relevance to Depressive-Like Behavior.

Authors:  Bruk Getachew; Rachel E Reyes; Daryl L Davies; Yousef Tizabi
Journal:  Clin Pharmacol Transl Med       Date:  2019-05-05

4.  A robust ambient temperature collection and stabilization strategy: Enabling worldwide functional studies of the human microbiome.

Authors:  Ericka L Anderson; Weizhong Li; Niels Klitgord; Sarah K Highlander; Mark Dayrit; Victor Seguritan; Shibu Yooseph; William Biggs; J Craig Venter; Karen E Nelson; Marcus B Jones
Journal:  Sci Rep       Date:  2016-08-25       Impact factor: 4.379

5.  Successful collection of stool samples for microbiome analyses from a large community-based population of elderly men.

Authors:  Melanie Abrahamson; Elizabeth Hooker; Nadim J Ajami; Joseph F Petrosino; Eric S Orwoll
Journal:  Contemp Clin Trials Commun       Date:  2017-07-06

6.  The effect of storage at ambient temperature on the feline fecal microbiota.

Authors:  Moran Tal; Adronie Verbrugghe; Diego E Gomez; Charlotte Chau; J Scott Weese
Journal:  BMC Vet Res       Date:  2017-08-18       Impact factor: 2.741

7.  Methodology challenges in studying human gut microbiota - effects of collection, storage, DNA extraction and next generation sequencing technologies.

Authors:  Marina Panek; Hana Čipčić Paljetak; Anja Barešić; Mihaela Perić; Mario Matijašić; Ivana Lojkić; Darija Vranešić Bender; Željko Krznarić; Donatella Verbanac
Journal:  Sci Rep       Date:  2018-03-23       Impact factor: 4.379

8.  New Insights into Clostridium difficile (CD) Infection in Latin America: Novel Description of Toxigenic Profiles of Diarrhea-Associated to CD in Bogotá, Colombia.

Authors:  Marina Muñoz; Dora I Ríos-Chaparro; Giovanny Herrera; Sara C Soto-De Leon; Claudia Birchenall; Darío Pinilla; Juan M Pardo-Oviedo; Diego F Josa; Manuel A Patarroyo; Juan D Ramírez
Journal:  Front Microbiol       Date:  2018-01-30       Impact factor: 5.640

9.  The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.

Authors:  Anna Heintz-Buschart; Urvashi Pandey; Tamara Wicke; Friederike Sixel-Döring; Annette Janzen; Elisabeth Sittig-Wiegand; Claudia Trenkwalder; Wolfgang H Oertel; Brit Mollenhauer; Paul Wilmes
Journal:  Mov Disord       Date:  2017-08-26       Impact factor: 10.338

10.  Effects of C-Terminal Domain of the Heavy Chain of Tetanus Toxin on Gut Microbiota in a Rat Model of Depression.

Authors:  Bruk Getachew; Yousef Tizabi
Journal:  Clin Pharmacol Transl Med       Date:  2019-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.